What is GB Sciences?
GB Sciences is a Las Vegas, Nevada-based entity focused on plant-based research, biopharmaceutical manufacturing, and drug development. The company operates at the intersection of botanical science and pharmaceutical innovation, aiming to leverage natural compounds for therapeutic applications. Its core business involves rigorous research and development, coupled with the manufacturing capabilities necessary to bring novel drug candidates to market.
How much funding has GB Sciences raised?
GB Sciences has raised a total of $3.9M across 1 funding round:
Debt
$3.9M
Debt (2017): $3.9M, investors not publicly disclosed
What's next for GB Sciences?
The substantial enterprise-level capital infusion positions GB Sciences for significant expansion and advancement in its drug development pipeline. This strategic backing is likely to accelerate research initiatives, enhance manufacturing infrastructure, and support clinical trials. As a company in the biopharmaceutical space, such financing is critical for navigating the complex and capital-intensive process of drug discovery and commercialization, suggesting a focus on scaling operations and achieving key developmental milestones.
See full GB Sciences company page
